Discovery and Preclinical Characterization of Benzofuran Derivatives as Potent, Selective, and Orally Bioavailable GSPT1 Molecular Glue Degraders for the Treatment of MYC-Driven Cancers
Journal of Medicinal Chemistry · 16.11.2026
DOI: 10.1021/acs.jmedchem.6c01738 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 16.11.2026. Verfasst von Zhimin Zhang und 9 weiteren Autor:innen. Die Arbeit nennt 56 Literaturangaben.
Abstract (Originalsprache)
Targeted protein degradation of the translation termination factor GSPT1 is a promising cancer strategy. However, current cereblon-recruiting molecular glue degraders (MGDs) lack structural diversity, being mostly IMiD derivatives. To overcome resistance and improve drug-like properties, we report the rational, structure-guided design of a novel series of benzofuran-based GSPT1 MGDs. Extensive structure−activity relationship studies and optimization led to the discovery of highly potent, orally bioavailable degraders, highlighted by compounds C-3 and C-4. Both exhibited single-digit nanomolar GSPT1 degradation (DC50 = 2.81 and 1.91 nM) and robust selectivity over IMiD off-targets IKZF1 and SALL4. In vivo, oral administration (1−2 mg/kg) of C-3 and C-4 demonstrated favorable cross-species pharmacokinetics and achieved sustained tumor regression in NCI-H1155 and MDA-MB-468 xenograft models. With a maximum tolerated dose exceeding 100 mg/kg and no hematological toxicity, these benzofuran-based MGDs are highly promising preclinical candidates for solid tumors.
Zitieren
APA
Zhang, Z., Chang, Y., Teng, L., Cai, C., Deng, X., Zhang, X., E, J., He, J., Zhao, M., & Liu, D. (2026). Discovery and Preclinical Characterization of Benzofuran Derivatives as Potent, Selective, and Orally Bioavailable GSPT1 Molecular Glue Degraders for the Treatment of MYC-Driven Cancers. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c01738
Vancouver
Zhang Z, Chang Y, Teng L, Cai C, Deng X, Zhang X, et al. Discovery and Preclinical Characterization of Benzofuran Derivatives as Potent, Selective, and Orally Bioavailable GSPT1 Molecular Glue Degraders for the Treatment of MYC-Driven Cancers. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.6c01738
BibTeX
@article{Zhang2026,
author = {Zhang, Zhimin and Chang, Yujie and Teng, Li and Cai, Cancan and Deng, Xiaoyan and Zhang, Xiaohua and E, Jingwen and He, Jiangqi and Zhao, Mengting and Liu, Dongzhou},
title = {Discovery and Preclinical Characterization of Benzofuran Derivatives as Potent, Selective, and Orally Bioavailable GSPT1 Molecular Glue Degraders for the Treatment of MYC-Driven Cancers},
journal = {Journal of Medicinal Chemistry},
year = {2026},
doi = {10.1021/acs.jmedchem.6c01738}
}
EUVIMED